These findings suggest that at this dose and time, medullary SPAK and/or NKCC2 are not direct or indirect targets of AngII signaling and, thus, are not likely to play a vital role in the development of AngII hypertension, rather, they appear key to the compensatory natriuretic adjustments after hypertension develops. The gene discussed is STK39; the disease is Hypertension.